Menu
Back to User profile » Dr Yasumasa Monobe
Papers published by Dr Yasumasa Monobe:
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy
Taoka M, Ochi N, Mimura A, Ichiyama N, Nagasaki Y, Nakagawa N, Nakanishi H, Yamane H, Oshiro Y, Monobe Y, Takigawa N
Therapeutics and Clinical Risk Management 2021, 17:571-575
Published Date: 3 June 2021
Descending necrotizing mediastinitis in a healthy young adult
Ochi N, Wakabayashi T, Urakami A, Yamatsuji T, Ikemoto N, Nagasaki Y, Nakagawa N, Honda Y, Nakanishi H, Yamane H, Monobe Y, Akisada T, Katayama H, Naomoto Y, Takigawa N
Therapeutics and Clinical Risk Management 2018, 14:2013-2017
Published Date: 17 October 2018
Herpetic esophagitis following bendamustine-containing regimen
Yamane H, Monobe Y, Tanikawa T, Ochi N, Honda Y, Kawamoto H, Takigawa N
Therapeutics and Clinical Risk Management 2016, 12:883-886
Published Date: 2 June 2016
Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma
Ochi N, Goto D, Yamane H, Yamagishi T, Honda Y, Monobe Y, Kawamoto H, Takigawa N
OncoTargets and Therapy 2014, 7:1847-1850
Published Date: 7 October 2014
Docetaxel for non small cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
Yamane H, Ochi N, Yasugi M, Tabayashi T, Yamagishi T, Monobe Y, Hisamoto A, Kiura K, Takigawa N
OncoTargets and Therapy 2013, 6:155-160
Published Date: 6 March 2013